Sinopharm News
Most Popular Sinopharm Story
Sanofi, Teva among Ratiopharm bidders
No wonder Ratiopharm's owner family was so pleased by the first round of buyout bids. If Bloomberg's sources are correct, a smorgasbord of offers came in from financial investors, branded drugmakers, Read more...
Latest Headlines
- January 11, 2011
- July 28, 2010
- April 7, 2010
- December 4, 2009
- November 12, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
